A comprehensive view of gsk group (glaxosmithkline). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

AstraZeneca asks court to block former Investor Relations VP from working at GSK due to noncompete agreement the VP signed in 2021; agreement prevents the VP from facilitating competition for six months
Published: August 17, 2022 by FiercePharma
GSK and IQVIA create Vaccine Track platform that allows public health officials, industry leaders to follow vaccination trends, uptake in US; platform tracks vaccinations trends across multiple vaccines, shows differences based on demographics
Published: August 11, 2022 by FiercePharma
23ANDME HOLDING CO. - 10-Q - Management's Discussion and Analysis of Financial Condition and Results of Operations
Published: August 09, 2022 by Edgar Glimpses
ZENTALIS PHARMACEUTICALS, INC. - 10-Q - Management's Discussion and Analysis of Financial Condition and Results of Operations.
Published: August 09, 2022 by Edgar Glimpses
Royalty Pharma buys royalty rights to GSK’s Trelegy Ellipta fluticasone furoate, umeclidinium, vilanterol from Theravance Respiratory for US$1.6B; Trelegy treats chronic obstructive pulmonary disease and asthma, had 2021 sales of US$1.7B
Published: July 19, 2022 by SeeNews Pharmaceuticals

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count